+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Treatment Type , By End User (Dermatological Clinics, Hospitals, and Others), By Disorder Type (Melasma, Age Spot, and Others). By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 117 Pages
  • March 2024
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5953773
The Asia Pacific Hyperpigmentation Treatment Market would witness market growth of 8.9% CAGR during the forecast period (2023-2030).

The China market dominated the Asia Pacific Hyperpigmentation Treatment Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $746.1 million by 2030. The Japan market is registering a CAGR of 8.2% during (2023 - 2030). Additionally, The India market would experience a CAGR of 9.6% during (2023 - 2030).



Hyperpigmentation treatments, including laser therapies and topical agents, diminish the appearance of these sun-induced pigmentations, restoring a more youthful and even complexion. Achieving an even skin tone is a common aesthetic goal for many individuals. Hyperpigmentation treatments, such as topical creams, serums, and laser therapies, help reduce the appearance of dark spots and blemishes, contributing to a smoother and more radiant complexion. Some hyperpigmentation treatments, particularly laser technologies, stimulate collagen production, improving skin texture. This can lead to smoother, more youthful-looking skin.

Laser-based hyperpigmentation treatments, such as laser tattoo removal, use targeted energy to break down pigmented particles in tattoos. This process helps fade and eventually eliminate the appearance of unwanted tattoos, catering to individuals seeking tattoo removal for personal or professional reasons. Hyperpigmentation can significantly impact an individual’s psychological well-being and self-esteem. Treating hyperpigmentation addresses physical concerns and improves confidence and self-worth, empowering individuals to feel better about their appearance. Hyperpigmentation treatments are not solely reactive but are increasingly used preventively. Individuals prone to hyperpigmentation, such as those with a history of melasma or sunspots, may incorporate topical agents and procedures into their skincare routines to prevent the development of new pigmentation issues.

According to Invest India, the growing middle-class population and rising disposable income will be important growth drivers for segments like premium beauty and personal care products, expected to grow by 54% between FY21-26. In addition, fragrances, makeup & cosmetics, and men’s grooming are all expected to expand by 20-40% between FY21-26. Therefore, due to the above-mentioned factors, the hyperpigmentation treatment market will grow significantly in this region.

Based on Treatment Type, the market is segmented into Topical Agent, Photo Therapy, and Microdermabrasion. Based on End User, the market is segmented into Dermatological Clinics, Hospitals, and Others. Based on Disorder Type, the market is segmented into Melasma, Age Spot, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • Vivier Pharma Inc.
  • Pierre Fabre S.A
  • Aerolase
  • L'Oréal S.A.
  • CP Skin Health Group, Inc. (The Colgate Palmolive Company)
  • Trophy Skin Products LLC
  • The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
  • Episciences, Inc.
  • The Procter and Gamble Company
  • Galderma S.A.

Market Report Segmentation

By Treatment Type
  • Topical Agent
  • Photo Therapy
  • Microdermabrasion
By End User
  • Dermatological Clinics
  • Hospitals
  • Others
By Disorder Type
  • Melasma
  • Age Spot
  • Others
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Hyperpigmentation Treatment Market, by Treatment Type
1.4.2 Asia Pacific Hyperpigmentation Treatment Market, by End User
1.4.3 Asia Pacific Hyperpigmentation Treatment Market, by Disorder Type
1.4.4 Asia Pacific Hyperpigmentation Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Asia Pacific Hyperpigmentation Treatment Market by Treatment Type
4.1 Asia Pacific Topical Agent Market by Country
4.2 Asia Pacific Photo Therapy Market by Country
4.3 Asia Pacific Microdermabrasion Market by Country
Chapter 5. Asia Pacific Hyperpigmentation Treatment Market by End User
5.1 Asia Pacific Dermatological Clinics Market by Country
5.2 Asia Pacific Hospitals Market by Country
5.3 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Hyperpigmentation Treatment Market by Disorder Type
6.1 Asia Pacific Melasma Market by Country
6.2 Asia Pacific Age Spot Market by Country
6.3 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Hyperpigmentation Treatment Market by Country
7.1 China Hyperpigmentation Treatment Market
7.1.1 China Hyperpigmentation Treatment Market by Treatment Type
7.1.2 China Hyperpigmentation Treatment Market by End User
7.1.3 China Hyperpigmentation Treatment Market by Disorder Type
7.2 Japan Hyperpigmentation Treatment Market
7.2.1 Japan Hyperpigmentation Treatment Market by Treatment Type
7.2.2 Japan Hyperpigmentation Treatment Market by End User
7.2.3 Japan Hyperpigmentation Treatment Market by Disorder Type
7.3 India Hyperpigmentation Treatment Market
7.3.1 India Hyperpigmentation Treatment Market by Treatment Type
7.3.2 India Hyperpigmentation Treatment Market by End User
7.3.3 India Hyperpigmentation Treatment Market by Disorder Type
7.4 South Korea Hyperpigmentation Treatment Market
7.4.1 South Korea Hyperpigmentation Treatment Market by Treatment Type
7.4.2 South Korea Hyperpigmentation Treatment Market by End User
7.4.3 South Korea Hyperpigmentation Treatment Market by Disorder Type
7.5 Singapore Hyperpigmentation Treatment Market
7.5.1 Singapore Hyperpigmentation Treatment Market by Treatment Type
7.5.2 Singapore Hyperpigmentation Treatment Market by End User
7.5.3 Singapore Hyperpigmentation Treatment Market by Disorder Type
7.6 Malaysia Hyperpigmentation Treatment Market
7.6.1 Malaysia Hyperpigmentation Treatment Market by Treatment Type
7.6.2 Malaysia Hyperpigmentation Treatment Market by End User
7.6.3 Malaysia Hyperpigmentation Treatment Market by Disorder Type
7.7 Rest of Asia Pacific Hyperpigmentation Treatment Market
7.7.1 Rest of Asia Pacific Hyperpigmentation Treatment Market by Treatment Type
7.7.2 Rest of Asia Pacific Hyperpigmentation Treatment Market by End User
7.7.3 Rest of Asia Pacific Hyperpigmentation Treatment Market by Disorder Type
Chapter 8. Company Profiles
8.1 Vivier Pharma Inc.
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Pierre Fabre S.A
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.2.3 SWOT Analysis
8.3 Aerolase
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 L'Oréal S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.5 SWOT Analysis
8.5 The Procter & Gamble Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Galderma S.A.
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 CP Skin Health Group, Inc. (The Colgate Palmolive Company)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Trophy Skin Products LLC
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. Episciences, Inc.
8.10.1 Company Overview
8.10.2 SWOT Analysis

Companies Mentioned

  • Vivier Pharma Inc.
  • Pierre Fabre S.A
  • Aerolase
  • L'Oréal S.A.
  • CP Skin Health Group, Inc. (The Colgate Palmolive Company)
  • Trophy Skin Products LLC
  • The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
  • Episciences, Inc.
  • The Procter and Gamble Company
  • Galderma S.A.

Methodology

Loading
LOADING...